These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2834700)

  • 1. Receptors for vasoactive intestinal peptide (VIP) on human mononuclear leucocytes are upregulated during prolonged strain and energy deficiency.
    Wiik P; Opstad PK; Knardahl S; Bøyum A
    Peptides; 1988; 9(1):181-6. PubMed ID: 2834700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homologous regulation of adenylate cyclase-coupled receptors for vasoactive intestinal peptide (VIP) on human mononuclear leucocytes.
    Wiik P
    Regul Pept; 1988 Apr; 20(4):323-33. PubMed ID: 2835796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoids upregulate the high affinity receptors for vasoactive intestinal peptide (VIP) on human mononuclear leucocytes in vitro.
    Wiik P
    Regul Pept; 1991 Jul; 35(1):19-30. PubMed ID: 1656488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VIP receptor subtypes in mouse cerebral cortex: evidence for a differential localization in astrocytes, microvessels and synaptosomal membranes.
    Martin JL; Feinstein DL; Yu N; Sorg O; Rossier C; Magistretti PJ
    Brain Res; 1992 Jul; 587(1):1-12. PubMed ID: 1326373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
    Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
    Gespach C; Bawab W; de Cremoux P; Calvo F
    Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology and molecular identification of vasoactive intestinal peptide (VIP) receptors in normal and cancerous gastric mucosa in man.
    Gespach C; Bawab W; Chastre E; Emami S; Yanaihara N; Rosselin G
    Biochem Biophys Res Commun; 1988 Mar; 151(2):939-47. PubMed ID: 2831906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective effect of castration on the anterior pituitary VIP receptor of male rats.
    Wanke IE; Huang M; Rorstad OP
    Peptides; 1990; 11(6):1157-61. PubMed ID: 1965030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of GTP analogs and dithiothreitol on the binding properties of the vascular vasoactive intestinal peptide receptor.
    Huang M; Rorstad OP
    Can J Physiol Pharmacol; 1989 Aug; 67(8):851-6. PubMed ID: 2557141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding and degradation of vasoactive intestinal peptide in prolactin-producing cultured rat pituitary tumour cells (GH4C1).
    Bjøro T; Wiik P; Opstad PK; Gautvik KM; Haug E
    Acta Physiol Scand; 1987 Aug; 130(4):609-18. PubMed ID: 2820199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptors for vasoactive intestinal peptide in rat anterior pituitary glands: localization of binding to lactotropes.
    Wanke IE; Rorstad OP
    Endocrinology; 1990 Apr; 126(4):1981-8. PubMed ID: 2156675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of vasoactive intestinal peptide (VIP) receptors in mammalian lung.
    Dickinson KE; Schachter M; Miles CM; Coy DH; Sever PS
    Peptides; 1986; 7(5):791-800. PubMed ID: 3025822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of vasoactive intestinal polypeptide binding sites in guinea pig genital tissues.
    Inyama CO; Wharton J; Davis CJ; Jackson RH; Bloom SR; Polak JM
    Neurosci Lett; 1987 Oct; 81(1-2):111-6. PubMed ID: 2827063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 1. Molecular characterization of the binding site.
    Luis J; Martin JM; el Battari A; Reynier M; Marvaldi J; Pichon J
    Eur J Biochem; 1989 Mar; 180(2):429-33. PubMed ID: 2538330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of vasoactive intestinal peptide receptors in retina.
    Swedlund AP; Rosenzweig SA
    Exp Eye Res; 1990 Sep; 51(3):317-23. PubMed ID: 2169429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal peptide receptor in failing human ventricular myocardium exhibits increased affinity and decreased density.
    Hershberger RE; Anderson FL; Bristow MR
    Circ Res; 1989 Aug; 65(2):283-94. PubMed ID: 2546693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective photolabeling of high and low affinity binding sites for vasoactive intestinal peptide (VIP): evidence for two classes of covalent VIP-receptor complexes in intestinal cell membranes.
    Robichon A; Marie JC
    Endocrinology; 1987 Mar; 120(3):978-85. PubMed ID: 3026793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of thymic peptide thymosin alpha 1 with vasoactive intestinal peptide (VIP) receptors.
    Calvo JR; Goberna R; Guerrero JM
    Biosci Rep; 1986 Aug; 6(8):727-33. PubMed ID: 3028522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localisation and characterisation of functional vasoactive intestinal peptide receptors in feline kidney.
    Griffiths NM; Simmons NL
    Pflugers Arch; 1990 Apr; 416(1-2):80-7. PubMed ID: 2162036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High affinity receptors for vasoactive intestinal peptide on a human glioma cell line.
    Nielsen FC; Gammeltoft S; Westermark B; Fahrenkrug J
    Peptides; 1990; 11(6):1225-31. PubMed ID: 1965033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.